News AZ's Alexion inks wide-ranging AI agreement with Verge AstraZeneca has made a sizeable play in applying artificial intelligence to drug discovery in its rare disease unit Alexion, partnering with Verge Genomics in a deal that
News Verge Genomics takes AI-sourced drug for ALS into clinic Verge Genomics has joined a select group of biotechs who have taken a drug discovered and developed using artificial intelligence into human testing.
Market Access Sponsored Bridging research and clinical guidelines – interactive stra... Medical affairs is evolving. Understanding how to harness real-world data and digital insights is essential.